MEDIGEN BIOTECHNOLOGY CORPORATION financial statements, including revenue, expenses, profit, and loss
The total revenue of 3176 for the last quarter is 251.32 M TWD, and it's 32.26% lower compared to the previous quarter. The net income of Q1 24 is -125.12 M TWD.